Craneware plc
("Craneware" or the "Company" or the "Group")
Purchase of Shares by Director and Total Voting Rights
28 April 2025 - Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, announces that on 24 April 2025, Will Whitehorn, Chair of the Company, purchased 1,911 Ordinary Shares of 1p each in the capital of the Company at a price of 1,584 pence per Ordinary Share.
Following the purchase of Ordinary Shares, Mr. Whitehorn holds 6,500 Ordinary Shares in the capital of the Company, representing 0.018% of the Company's issued share capital (excluding Ordinary Shares held in treasury).
Total Voting Rights
In the period since 1 April 2025 the Company has transferred a total of 1,118 Ordinary Shares previously held in treasury to satisfy the exercise of share options by employees. As a result, the Company's issued share capital now consists of 35,542,169 Ordinary Shares, of which 132,367 remain held in treasury. Accordingly, the total number of Ordinary Shares in the Company with voting rights is 35,409,802.This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:
1. Details of the Restricted Person / person closely associated with him or her
a) Name William Whitehorn
2. Reason for the notification
|
a) Position / status |
Chair |
|
b) Initial notification / Amendment |
Initial notification |
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
a) Name |
Craneware plc |
|
b) LEI |
213800O2CTJ1YFXNXG05 |
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
a) Description of the financial instrument, type of instrument |
Ordinary shares of 1p each in the capital of Craneware plc |
|
b) Identification code |
ISIN GB00B2425G68 |
|
c) Nature of the transaction |
Purchase of Ordinary Shares |
|
d) Price(s) and volume(s) |
Volume(s) 1,911, Price(s) £15.84 |
|
e) Aggregated information: |
N/A (single transaction) |
i. Aggregated volume -
ii. Price(s) -
|
f) Date of the transaction |
2025-04-24 |
|
g) Place of the transaction |
London Stock Exchange (XLON) |
For further information, please contact:
|
Craneware plc |
+44 (0)131 550 3100 |
|
Keith Neilson, CEO |
|
|
Craig Preston, CFO |
|
|
|
|
|
Alma Strategic Communications (Financial PR) |
+44 (0)20 3405 0205 |
|
Caroline Forde, Kinvara Verdon, Sarah Peters |
craneware@almastrategic.com |
|
|
|
|
Peel Hunt (NOMAD and Joint Broker) |
+44 (0)20 7418 8900 |
|
Neil Patel, Benjamin Cryer, Kate Bannatyne |
|
|
|
|
|
Investec Bank PLC (Joint Broker) |
+44 (0)20 7597 5970 |
|
Patrick Robb, Virginia Bull, James Smith |
|
|
|
|
|
Berenberg (Joint Broker) |
+44 (0)20 3207 7800 |
|
Mark Whitmore, Richard Andrews, Dan Gee-Summons |
|
About Craneware
The Craneware Group (AIM:CRW.L), is the market leader in value cycle solutions. For 25 years, we have collaborated with U.S. healthcare providers to optimize revenue integrity, pricing intelligence, decision support, labor productivity, business of pharmacy, and 340B program management.
Customers choose Trisus®, a HITRUST- and SOC2 Type II-certified, SaaS platform, to achieve operational and financial excellence in pursuit of their healthcare mission - delivering quality care to their communities. The Craneware Group - Transforming the Business of Healthcare.
Learn more at www.thecranewaregroup.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
